Efficacy of Therapeutic Education for Patients With Rheumatoid Arthritis Treated With Biologics.

IF 1.5 Q3 RHEUMATOLOGY

Musculoskeletal Care Pub Date : 2025-03-01 DOI:10.1002/msc.70060

Selma Bouden, Hiba Ben Ayed, Haifa Khemir, Leila Rouached, Aicha Ben Tekaya, Ines Mahmoud, Raoudha Tekaya, Olfa Saidane, Leila Abdelmoula

{"title":"Efficacy of Therapeutic Education for Patients With Rheumatoid Arthritis Treated With Biologics.","authors":"Selma Bouden, Hiba Ben Ayed, Haifa Khemir, Leila Rouached, Aicha Ben Tekaya, Ines Mahmoud, Raoudha Tekaya, Olfa Saidane, Leila Abdelmoula","doi":"10.1002/msc.70060","DOIUrl":null,"url":null,"abstract":"Introduction: We aimed to assess the effects of a patient therapeutic education (PTE) programme on the course of the disease and treatment management skills in rheumatoid arthritis (RA) patients treated with biologics.Methods: From January to December 2023, 52 RA patients participated in a face-to-face education session of 1 h, delivered to groups of four to six patients by 2 rheumatologists qualified in PTE. Disease activity, quality of life parameters and patient's skills using the BioSecure score were assessed before the education programme and 3 months later.Results: A statistically significant decrease in mean pain visual Analogue Scale (p = 0.001), mean morning stiffness duration (p = 0.002), mean number of night awakenings (p = 0.01), mean tender joints count (p = 0.001) and mean 28-Disease-activity-score (p = 0.001) were observed 3 months after the PTE. A statistically significant decrease in functional status (HAQ) and fatigue scores (FACIT-F) was observed after PTE (p = 0.03 and p = 0.001, respectively). The mean BioSecure score climbed from 47.9 ± 14.9 at baseline to 74.8 ± 12.9 after PTE (p = 0.001). The variation of BioSecure score was significantly more important in patients with third-level education, patients receiving subcutaneous biotherapy and those on TNF alpha inhibitors therapy.Conclusion: PTE may be effective in improving clinical outcomes and safety skills in RA patients receiving biological treatment.","PeriodicalId":46945,"journal":{"name":"Musculoskeletal Care","volume":"23 1","pages":"e70060"},"PeriodicalIF":1.5000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Musculoskeletal Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/msc.70060","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: We aimed to assess the effects of a patient therapeutic education (PTE) programme on the course of the disease and treatment management skills in rheumatoid arthritis (RA) patients treated with biologics.

Methods: From January to December 2023, 52 RA patients participated in a face-to-face education session of 1 h, delivered to groups of four to six patients by 2 rheumatologists qualified in PTE. Disease activity, quality of life parameters and patient's skills using the BioSecure score were assessed before the education programme and 3 months later.

Results: A statistically significant decrease in mean pain visual Analogue Scale (p = 0.001), mean morning stiffness duration (p = 0.002), mean number of night awakenings (p = 0.01), mean tender joints count (p = 0.001) and mean 28-Disease-activity-score (p = 0.001) were observed 3 months after the PTE. A statistically significant decrease in functional status (HAQ) and fatigue scores (FACIT-F) was observed after PTE (p = 0.03 and p = 0.001, respectively). The mean BioSecure score climbed from 47.9 ± 14.9 at baseline to 74.8 ± 12.9 after PTE (p = 0.001). The variation of BioSecure score was significantly more important in patients with third-level education, patients receiving subcutaneous biotherapy and those on TNF alpha inhibitors therapy.

Conclusion: PTE may be effective in improving clinical outcomes and safety skills in RA patients receiving biological treatment.

查看原文本刊更多论文

类风湿关节炎生物制剂治疗教育的疗效观察

前言：我们旨在评估患者治疗教育（PTE）计划对类风湿关节炎（RA）患者接受生物制剂治疗的病程和治疗管理技能的影响。方法：2023年1月至12月，52例RA患者参加了1小时的面对面教育课程，由2名具有PTE资格的风湿病学家向4至6名患者提供，在教育计划开始前和3个月后使用BioSecure评分评估疾病活动性、生活质量参数和患者技能。结果：PTE治疗后3个月患者的平均疼痛视觉模拟量表（p = 0.001）、平均晨僵时间（p = 0.002）、平均夜间醒来次数（p = 0.01）、平均压痛关节数（p = 0.001）和平均28-疾病-活动评分（p = 0.001）均有统计学意义降低，功能状态（HAQ）和疲劳评分（FACIT-F）均有统计学意义降低（p = 0.03和p = 0.001）。平均BioSecure评分从基线时的47.9±14.9分上升至PTE后的74.8±12.9分（p = 0.001）。在三级教育程度的患者、接受皮下生物治疗的患者和接受TNF α抑制剂治疗的患者中，BioSecure评分的变化更为重要。结论：PTE可有效改善RA患者接受生物治疗的临床结局和安全技能。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Musculoskeletal Care RHEUMATOLOGY-

CiteScore

2.30

自引率

7.70%

发文量

期刊介绍： Musculoskeletal Care is a peer-reviewed journal for all health professionals committed to the clinical delivery of high quality care for people with musculoskeletal conditions and providing knowledge to support decision making by professionals, patients and policy makers. This journal publishes papers on original research, applied research, review articles and clinical guidelines. Regular topics include patient education, psychological and social impact, patient experiences of health care, clinical up dates and the effectiveness of therapy.